e.pires
TL2 Moderator · Uppsala
Contributes reviews on supplier material. Based in Uppsala.
Joined 21 August 2025 · last posted 23h
84 posts, newest first. Showing up to 150.
-
What a reversed-phase purity number actually is Replied, post #99 · Analytics › HPLC & UHPLC · 27 Jul 2026 · 1 like Gradient slope is the single biggest driver of apparent purity differences. A shallower gradient over a longer run resolves more impurities and gives a higher purity…
-
What to bring: records that a clinician can actually use Replied, post #19 · Clinical › Prescriber conversations · 26 Jul 2026 · 18 likes Preparing for an appointment: bring recent bloodwork, a list of current medications with doses and timing, and any questions written out. Written questions get better…
-
Named, unnamed and unspecified impurities as regulatory categories — the long version Replied, post #115 · Analytics › Impurities & related substances · 26 Jul 2026 · 18 likes Disulfide formation: if a peptide contains cysteine, it can form disulfide bonds with itself or with other molecules. Under oxidising conditions multiple species…
-
Muscle cramps: the ordinary causes before the exotic ones — a second dataset Replied, post #75 · Practice › Side effects · 25 Jul 2026 · 1 like On post #71 — agreed on the reasoning, with one qualification. Constipation: common, manageable, and frequently under-reported because it is not dramatic. Increasing…
-
Reading U-100 graduations, with a conversion table Replied, post #41 · Devices › Syringes & needles · 22 Jul 2026 · 21 likes Needle gauge: smaller numbers (30G) are finer and less painful. Larger numbers (25G) are courser. For subcutaneous injection, 27-30G is typical. Finer needles take…
-
Asking a follow-up: new topic or new reply? Replied, post #62 · Start Here › How to Ask · 20 Jul 2026 · 14 likes Disagreement-style questions: "I read this and it contradicts what I heard here, which is right?" is answerable. "Is this a bad idea?" without giving the context is not.
-
Revisiting: The report format the maintainers ask for, and why each field is there Replied, post #103 · Sourcing › Vendor reports · 17 Jul 2026 · 32 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Review: a draft on reconstitution arithmetic, with objections — one year on Replied, post #44 · Documentation › Doc review · 14 Jul 2026 · 9 likes Review date disputes: if a maintained page's review date is approaching and it has not been updated, post a note so the maintainers notice.
-
Request: a per-category review queue Replied, post #85 · Meta › Feature requests · 7 Jul 2026 · 0 likes Community support: if other people support your request, they can reply with "+1" or "I would use that too". Widely-requested features are prioritised.
-
How much context is too much context in a first post? Replied, post #22 · Start Here › How to Ask · 6 Jul 2026 · 19 likes post #21 answers the question as asked. The question underneath it is different. Asking a follow-up: new topic or reply in the old one? If the answer depends on the…
-
A single out-of-range value on an otherwise normal panel Replied, post #67 · Clinical › Bloodwork · 2 Jul 2026 · 9 likes Reference intervals: constructed to contain the central 95% of a reference population, which means one in twenty healthy people falls outside one by definition. Add…
-
Pages past their review date, listed — does this still hold? Replied, post #19 · Meta › Wiki maintenance · 20 Jun 2026 · 0 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Coming back to: Time to steady state after a dose increase Replied, post #81 · Pharmacology › Pharmacokinetics · 20 Jun 2026 · 5 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Follow-up: The retatrutide phase 2 obesity paper, read closely Replied, post #18 · Compounds › Retatrutide · 16 Jun 2026 · 26 likes On post #14 — agreed on the reasoning, with one qualification. Mass and identity: a report on retatrutide should state the mass detected by LC-MS, not assume a…
-
Pooling trials with different estimands Replied, post #19 · Evidence › Meta-analyses · 11 Jun 2026 · 1 like Worth separating two things that post #15 runs together. Publication bias: what did not get published? Small studies with negative results are less likely to be…
-
A reconstituted vial's beyond-use date and the reasoning behind common figures Replied, post #53 · Practice › Storage & stability · 5 Jun 2026 · 4 likes Refrigeration slows degradation. Repeated warming and cooling is worse than continuous refrigeration. Light exposure is worth avoiding. The concentration matters…
-
An appeal that succeeded, with the letter structure — the long version Replied, post #32 · Access › Insurance & coverage · 30 May 2026 · 12 likes Prior authorisation: pre-approval requirements and how to satisfy them. Most denials cite specific criteria. Understanding the criterion is the first step in satisfying…
-
Comparing prices across jurisdictions without misleading yourself Replied, post #13 · Access › Pricing · 28 May 2026 · 7 likes post #12 answers the question as asked. The question underneath it is different. I disagree with the reply above, and I think the disagreement is substantive rather…
-
[2026 update] 0.3 mL versus 0.5 mL versus 1 mL barrels: resolution matters Replied, post #123 · Devices › Syringes & needles · 15 May 2026 · 0 likes Reading units correctly: look at the marking from the side, not from above or below. The bottom of the plunger tip is the reading. Parallax error (wrong angle) is a…
-
Reading a trial's population section before its results Replied, post #20 · Evidence › Trials · 14 May 2026 · 2 likes Multiplicity and multiple comparisons: if a trial tests many hypotheses, the chance of a false positive on at least one by random chance increases. This is why…
-
Revisiting: What pooling buys you and what it destroys Replied, post #18 · Evidence › Meta-analyses · 10 May 2026 · 22 likes Picking up post #15: that is the part I would want checked first. Why forest plots are more informative than pooled numbers: they show the variation across studies,…
-
Designing a personal experiment that could change your mind — one year on Replied, post #32 · Research Methods › N-of-1 designs · 12 Apr 2026 · 6 likes Generalisability: a robust n-of-1 result applies to you. It does not tell you much about whether the effect generalises to others similar to you, much less to people…
-
Follow-up: Evidence quality in the secretagogue literature: an honest assessment Replied, post #24 · Compounds › Secretagogues & GH axis · 5 Apr 2026 · 26 likes Coming back to post #22, because the follow-up matters more than the original answer. Reading a rodent study on a secretagogue without over-extrapolating: rodent…
-
Revisiting: Journal club: SURMOUNT-1, read without the press release Replied, post #31 · Evidence › Journal club · 1 Apr 2026 · 4 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Molecular mass of semaglutide and why the figure differs between sources Replied, post #19 · Compounds › Semaglutide · 15 Mar 2026 · 7 likes This follows post #16 rather than contradicting it. Albumin binding is not a unique structural feature and nothing in the class lacks it, but the reversibility matters.…
-
What a certificate commits its issuer to — one year on Replied, post #29 · Analytics › COA interpretation · 9 Mar 2026 · 19 likes Amino acid analysis gives content: it hydrolyses the peptide and quantifies the residues. It measures the peptide content independent of chromatographic purity. Very…
-
Sample size intuition for a personal experiment — does this still hold? Replied, post #6 · Research Methods › Statistics · 6 Mar 2026 · 4 likes P-values and significance: p
-
[2026 update] Amylin and gastric emptying: overlapping mechanisms with incretins Replied, post #15 · Compounds › Cagrilintide & amylin analogues · 1 Mar 2026 · 0 likes This follows post #12 rather than contradicting it. Reading the phase 2 paper: it establishes tolerability and efficacy in a selected population on a defined dose…
-
Coming back to: Reading a supplier's product description as a marketing document Replied, post #32 · Compounds › Other compounds · 21 Feb 2026 · 31 likes Melanocortin agonists: mechanism involves the melanocortin-4 receptor pathway that regulates appetite. The documented adverse profile includes blood pressure elevation…
-
Second pass at: The topic list is dense — is that deliberate? Replied, post #70 · Meta › Site feedback · 12 Feb 2026 · 0 likes post #69 answers the question as asked. The question underneath it is different. Performance: if pages are slow to load, timeouts occur, or the site is unresponsive,…
-
[2026 update] A rising related-substance total over six months: degradation or method… Replied, post #19 · Analytics › Impurities & related substances · 11 Feb 2026 · 0 likes Residual solvents: traces of solvents used in purification. These are usually tested by gas chromatography, not by HPLC. A specification for residual solvents should be…
-
Follow-up: A supplier that answers analytical questions with restated claims Replied, post #80 · Sourcing › Red flags · 6 Feb 2026 · 13 likes Exaggerated claims without documentation: every compound has limits. No peptide is "100% pure" because purity is measured to finite precision. A supplier claiming…
-
[2026 update] Long-time reader, first-time poster Replied, post #46 · Lounge › Introductions · 30 Jan 2026 · 1 like post #45 is right about the mechanism and I think understates the practical bit. Community culture: introductions give you a sense of who is here. Reading a few…
-
Whether protein timing matters at a large deficit Replied, post #18 · Nutrition & Training › Protein & intake · 20 Jan 2026 · 0 likes Leucine and MPS: leucine stimulates muscle protein synthesis at a threshold of roughly 2 to 3 grams per meal. That influences how much protein per meal matters, but…
-
Run-in periods and the population they select Replied, post #43 · Evidence › Trials · 31 Dec 2025 · 3 likes Open-label design: unblinded trials admit expectation effects. For weight-loss trials where one arm loses substantial weight and the other does not, complete blinding…
-
Vomiting: when it is expected and when it is a reason to stop Replied, post #50 · Practice › Side effects · 28 Dec 2025 · 2 likes Nausea: the most common side effect and the most dose- and titration-dependent one. It is usually most prominent in the first 24 to 48 hours after injection and…
-
Micro-titration: a disputed topic, argued properly Replied, post #15 · Practice › Dosing & titration · 24 Dec 2025 · 8 likes The arithmetic of an intermediate dose: if the label says 1.0 mg and 2.0 mg, a dose strictly between them is off-label by definition. Some people compute it anyway. The…
-
The decimal-point error, and the habit that catches it Replied, post #109 · Practice › Reconstitution · 18 Dec 2025 · 4 likes post #108 answers the question as asked. The question underneath it is different. Over-dilution: if your target dose is 0.25 mg and your syringe is a 1 mL insulin…
-
The decimal-point error, and the habit that catches it Replied, post #72 · Practice › Reconstitution · 16 Dec 2025 · 5 likes I read post #70 twice before replying, because I had assumed the opposite. Choosing a concentration on purpose rather than by accident: starting with "I want to draw…
-
Stepping down deliberately, and how to do it without losing progress Replied, post #23 · Practice › Dosing & titration · 4 Dec 2025 · 1 like Stepping down deliberately: the withdrawal trials show that stopping is followed by regain. The step-down literature is thinner. The conservative assumption is that…
-
Common supplements people ask about, assessed one at a time — a second dataset Replied, post #15 · Practice › Interactions · 3 Dec 2025 · 2 likes Alcohol: no absolute contraindication but it raises gastrointestinal irritation risk and this drug class already does that. The conservative position during titration…
-
Pen dose counters: what a click does and does not guarantee Replied, post #80 · Devices › Pens & autoinjectors · 18 Nov 2025 · 31 likes Injection duration: most pens deliver the dose over several seconds. Holding the button down for the full duration ensures complete delivery. Releasing early can result…
-
A parcel that arrived warm: a decision process, not a verdict Replied, post #140 · Practice › Storage & stability · 15 Nov 2025 · 26 likes post #139 is right about the mechanism and I think understates the practical bit. I disagree with the reply above, and I think the disagreement is substantive rather…
-
Second pass at: Circumference measurements as a poor man's composition estimate Replied, post #9 · Outcomes › Body composition · 26 Oct 2025 · 16 likes I read post #7 twice before replying, because I had assumed the opposite. Changes during titration: measuring body composition during active titration is less useful…
-
Reverse causation in a cohort study of weight and outcome — a second dataset Replied, post #51 · Evidence › Study critique · 14 Sep 2025 · 0 likes Defending a paper against criticism: if the authors respond, they might clarify something the paper explained poorly. Their response might also miss your point. Either…
-
Liver enzymes drifting down and what that usually means Replied, post #11 · Clinical › Bloodwork · 14 Sep 2025 · 32 likes Picking up post #8: that is the part I would want checked first. Biological variation: the person-to-person variation in a biomarker for a healthy person is larger than…
-
Journal club: STEP-HFpEF and symptom endpoints Replied, post #2 · Evidence › Journal club · 30 Aug 2025 · 12 likes This follows the opening post rather than contradicting it. SURPASS-2 (N Engl J Med 2021): Direct comparison of tirzepatide with semaglutide 1.0 mg. The 1.0 mg dose is…
-
How to research a compound with no human data without deceiving yourself Replied, post #20 · Compounds › Other compounds · 30 Jul 2025 · 0 likes How to research a compound with no human data: mechanistic plausibility is one input. Preclinical data is another. The honest position is that you are reasoning from…
-
Reaching a dose and staying there for a year: a longitudinal note — does this still hold? Replied, post #13 · Practice › Dosing & titration · 17 Jul 2025 · 0 likes Titrating on tolerability rather than on the calendar: some people escalate when they tolerate a dose well, others escalate on the prescribed schedule regardless. The…
-
What this community means by "a source", in practical terms Replied, post #20 · Start Here › Welcome · 30 Jun 2025 · 0 likes post #19 answers the question as asked. The question underneath it is different. Off-topic posts that do not belong here belong in the Lounge instead. You are not in…
-
Which panel is worth repeating and which is worth ignoring Replied, post #48 · Clinical › Bloodwork · 28 Jun 2025 · 0 likes Reference intervals: constructed to contain the central 95% of a reference population, which means one in twenty healthy people falls outside one by definition. Add…
-
Forced degradation studies: designing one that is informative — does this still hold? Replied, post #18 · Analytics › Method validation · 18 Jun 2025 · 0 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
A report I filed that turned out to be wrong, and the correction Replied, post #103 · Sourcing › Vendor reports · 15 Jun 2025 · 0 likes Picking up post #100: that is the part I would want checked first. For anyone arriving from a search: the marked solution above is the direct answer, and the replies…
-
[2026 update] Constipation management, with a dietitian's contribution Replied, post #3 · Practice › Side effects · 4 Jun 2025 · 0 likes Worth separating two things that the opening post runs together. Fatigue: commonly reported, frequently multifactorial. It is worth asking whether other factors have…
-
Why oral semaglutide needs an absorption enhancer at all Replied, post #8 · Compounds › Oral incretins · 25 May 2025 · 11 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Travel coolers and how long they really hold — the long version Replied, post #23 · Devices › Cold chain · 23 May 2025 · 4 likes Temperature excursions: brief excursions above 8 °C are tolerable for most compounds. Hours to a day at room temperature is usually acceptable. Days to weeks at room…
-
Titles that describe the question, not the situation Replied, post #11 · Start Here › How to Ask · 15 May 2025 · 11 likes The specific question in the title is more useful than you might think. A title like "a question I have" forces the person answering to guess what you want to know. A…
-
Coming back to: Official shortage notices and what they authorise Replied, post #6 · Access › Shortages · 13 May 2025 · 32 likes post #5 answers the question as asked. The question underneath it is different. Managing an unplanned gap: if a shortage causes a gap in treatment, the questions are…
-
Reading an MS report that only gives you a single number Replied, post #67 · Analytics › Mass spectrometry · 1 May 2025 · 1 like This follows post #64 rather than contradicting it. Purity and identity are different questions: LC-MS establishes that the species at a retention time has the expected…
-
Water content on a certificate and why it changes the arithmetic Replied, post #2 · Analytics › COA interpretation · 19 Apr 2025 · 2 likes Endotoxin testing is separate: a certificate of purity says nothing about endotoxin. A chemically pure preparation can carry a clinically significant endotoxin load. If…
-
Coverage for the indication versus for the drug — a second dataset Replied, post #27 · Access › Insurance & coverage · 19 Mar 2025 · 29 likes Formulary status: the list of covered medications and the tier (how much you pay) they are on. Checking the current formulary before going to a clinic appointment saves…
-
Pharmaceutical compounding rules, summarised from primary sources Replied, post #160 · Sourcing › Regulatory · 6 Mar 2025 · 8 likes post #159 answers the question as asked. The question underneath it is different. Primary documents matter: regulatory positions are published in official documents.…
-
Second pass at: Cross-border purchase within the EU: the actual rules Replied, post #77 · Access › International · 4 Mar 2025 · 0 likes I read post #75 twice before replying, because I had assumed the opposite. Having read the exchange above, I think I was wrong earlier in this topic and I want to say…
-
Journal club: SURMOUNT-OSA and a hard endpoint in a soft field Replied, post #19 · Evidence › Journal club · 2 Mar 2025 · 3 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Counter-ion form: the field almost nobody reports — one year on Replied, post #13 · Analytics › COA interpretation · 20 Feb 2025 · 30 likes Coming back to post #11, because the follow-up matters more than the original answer. Reading old certificates: if a certificate is dated years ago, the lot it…
-
[2026 update] Lipid changes during rapid weight loss: the expected trajectory Replied, post #42 · Clinical › Bloodwork · 3 Feb 2025 · 24 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Research-use-only labelling: what it means and what it does not — the long version Replied, post #73 · Sourcing › Regulatory · 28 Jan 2025 · 17 likes I read post #71 twice before replying, because I had assumed the opposite. Primary documents matter: regulatory positions are published in official documents. Reading…
-
Second pass at: Regression to the mean in progress reports Replied, post #32 · Research Methods › Statistics · 22 Jan 2025 · 17 likes Regression to the mean: if you select people with extreme values (very high or very low), their next measurement is often less extreme just by chance. This can look…
-
Individual participant data versus aggregate data Replied, post #13 · Evidence › Meta-analyses · 1 Jan 2025 · 3 likes Worth separating two things that post #9 runs together. Inclusion and exclusion criteria: a meta-analysis is only as good as its inclusion criteria. If the criteria are…
-
Follow-up: Tirzepatide's shorter half-life and its one practical consequence Replied, post #111 · Compounds › Tirzepatide · 26 Dec 2024 · 32 likes Dual agonism versus dose: how much of tirzepatide's effect is the GIP component and how much is simply achieving higher receptor engagement? The honest answer is that…
-
Anaesthesia and elective surgery: the aspiration question — does this still hold? Replied, post #14 · Practice › Interactions · 22 Dec 2024 · 0 likes Coming back to post #12, because the follow-up matters more than the original answer. Two things before anyone answers the substance. First, the context in the first…
-
Fixed versus detachable needles: the trade-offs Replied, post #54 · Devices › Syringes & needles · 16 Dec 2024 · 1 like Sharps disposal: needles and syringes should be disposed in a sharps container (a rigid, puncture-resistant container). Do not put them in regular trash. Many…
-
Revisiting: Bug report: the reconstitution calculator and a rounding edge case Replied, post #20 · Data & Tools › Calculators · 15 Dec 2024 · 31 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Triple agonism: additive, synergistic, or neither? Replied, post #2 · Compounds › Retatrutide · 4 Dec 2024 · 4 likes This follows the opening post rather than contradicting it. Phase 2 sample sizes are not adequate for safety characterisation of a novel triple agonist. Phase 3 is…
-
Promotion criteria, and the one that stops most nominations Replied, post #114 · Documentation › Doc review · 16 Nov 2024 · 0 likes Review of promoted topics: when a topic is nominated for promotion to a maintained documentation page, the draft is posted here. Community review happens before…
-
Reading a preclinical wound-healing model and its relevance to a human tendon Replied, post #25 · Compounds › Repair & healing peptides · 10 Nov 2024 · 13 likes post #24 is right about the mechanism and I think understates the practical bit. The absence of adequately powered published randomised human trials is the central fact…
-
Second pass at: Hoarding and why it makes a shortage worse Replied, post #43 · Access › Shortages · 10 Oct 2024 · 2 likes Supply interruptions: official shortage notices are published by regulatory agencies. That is the correct primary source rather than pharmacy rumors or forum discussion.
-
Converting between mg/mL and units per dose, both directions Replied, post #35 · Practice › Reconstitution · 30 Sep 2024 · 22 likes Worth separating two things that post #31 runs together. Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather…
-
Follow-up: Where the four-week escalation interval comes from, and what it is not Replied, post #71 · Practice › Dosing & titration · 26 Sep 2024 · 4 likes Titrating on tolerability rather than on the calendar: some people escalate when they tolerate a dose well, others escalate on the prescribed schedule regardless. The…
-
SURPASS-2 and the comparator dose question that will not go away Replied, post #22 · Compounds › Tirzepatide · 25 Sep 2024 · 0 likes Picking up post #19: that is the part I would want checked first. Mass and charge states: tirzepatide is about 4813.5 Da and on an electrospray instrument you would…
-
Priming a pen and whether the primed volume is wasted — one year on Started this topic · Devices › Pens & autoinjectors · 14 Aug 2024 · 50 likes Posting this under the heading it deserves: Priming a pen and whether the primed volume is wasted — one year on Everything below is what sits behind that. Practical…
-
Second pass at: Retatrutide dose escalation in the published trials Replied, post #49 · Compounds › Retatrutide · 19 Jul 2024 · 22 likes Hepatic effects: glucagon receptor agonism promotes hepatic fat oxidation, which is mechanistically plausible for benefit in metabolic liver disease. Whether that…
-
Second pass at: Journal club: LEADER as the historical anchor Replied, post #27 · Evidence › Journal club · 14 Jul 2024 · 18 likes post #26 answers the question as asked. The question underneath it is different. SURMOUNT-OSA (N Engl J Med 2024): Tirzepatide in obstructive sleep apnoea, using an…
-
Oral contraceptives and delayed emptying: what the data shows Replied, post #23 · Practice › Interactions · 10 Jul 2024 · 0 likes SGLT2 inhibitors: frequently co-administered and relevant to renal and cardiovascular discussion, not to interactions. There is no pharmacokinetic interaction of concern.